{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T20:13:13Z","timestamp":1772741593006,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Mid-career Researcher Program","award":["2016R1A2B4011124"],"award-info":[{"award-number":["2016R1A2B4011124"]}]},{"name":"The KRIBB research Initiative Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00018-019-03066-9","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T18:03:28Z","timestamp":1553277808000},"page":"2647-2662","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Stabilization of E2-EPF UCP protein is implicated in hepatitis B virus-associated hepatocellular carcinoma progression"],"prefix":"10.1007","volume":"76","author":[{"given":"Jung Hwa","family":"Lim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Ghon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Yeul","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Mi","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Hee","family":"Noh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmin","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tae Kyung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Soo","family":"Im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cho-Rok","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,22]]},"reference":[{"key":"3066_CR1","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.3748\/wjg.v13.i23.3176","volume":"13","author":"G Bangoura","year":"2007","unstructured":"Bangoura G, Liu Z-S, Qian Q, Jiang C-Q, Yang G-F, Jing S (2007) Prognostic significance of HIF-2\u03b1\/EPAS1 expression in hepatocellular carcinoma. World J Gastroenterol WJG 13:3176","journal-title":"World J Gastroenterol WJG"},{"key":"3066_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.3748\/wjg.v10.i4.525","volume":"10","author":"G Bangoura","year":"2004","unstructured":"Bangoura G, Yang L-Y, Huang G-W, Wang W (2004) Expression of HIF-2\u03b1\/EPAS1 in hepatocellular carcinoma. World J Gastroenterol 10:525","journal-title":"World J Gastroenterol"},{"key":"3066_CR3","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1128\/JVI.72.1.266-272.1998","volume":"72","author":"SA Becker","year":"1998","unstructured":"Becker SA, Lee T-H, Butel JS, Slagle BL (1998) Hepatitis B virus X protein interferes with cellular DNA repair. J Virol 72:266\u2013272","journal-title":"J Virol"},{"key":"3066_CR4","first-page":"791","volume":"270","author":"RL Bilton","year":"2003","unstructured":"Bilton RL, Booker GW (2003) The subtle side to hypoxia inducible factor (HIF\u03b1) regulation. FEBS J 270:791\u2013798","journal-title":"FEBS J"},{"key":"3066_CR5","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1053\/j.gastro.2004.09.016","volume":"127","author":"C Br\u00e9chot","year":"2004","unstructured":"Br\u00e9chot C (2004) Pathogenesis of hepatitis B virus\u2014related hepatocellular carcinoma: old and new paradigms. Gastroenterology 127:S56\u2013S61","journal-title":"Gastroenterology"},{"key":"3066_CR6","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2015","unstructured":"Colaprico A et al (2015) TCGAbiolinks: an R\/bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res 44:e71\u2013e71","journal-title":"Nucleic Acids Res"},{"key":"3066_CR7","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature17170","volume":"531","author":"A Decorsi\u00e8re","year":"2016","unstructured":"Decorsi\u00e8re A et al (2016) Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor. Nature 531:386\u2013389","journal-title":"Nature"},{"key":"3066_CR8","doi-asserted-by":"crossref","unstructured":"Di Bisceglie AM (2009) Hepatitis B and hepatocellular carcinoma. Hepatology 49.S5:S56\u2013S60","DOI":"10.1002\/hep.22962"},{"key":"3066_CR9","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/nprot.2009.97","volume":"4","author":"S Durinck","year":"2009","unstructured":"Durinck S, Spellman PT, Birney E, Huber W (2009) Mapping identifiers for the integration of genomic datasets with the R\/bioconductor package biomaRt. Nat Protoc 4:1184","journal-title":"Nat Protoc"},{"key":"3066_CR10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ncb3312","volume":"18","author":"A Fatehullah","year":"2016","unstructured":"Fatehullah A, Tan SH, Barker N (2016) Organoids as an in vitro model of human development and disease. Nat Cell Biol 18:246","journal-title":"Nat Cell Biol"},{"key":"3066_CR11","first-page":"3566","volume":"58","author":"K Gottlob","year":"1998","unstructured":"Gottlob K, Pagano S, Levrero M, Graessmann A (1998) Hepatitis B virus X protein transcription activation domains are neither required nor sufficient for cell transformation. Can Res 58:3566\u20133570","journal-title":"Can Res"},{"key":"3066_CR12","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.1128\/JVI.73.9.7231-7240.1999","volume":"73","author":"Z Hu","year":"1999","unstructured":"Hu Z, Zhang Z, Doo E, Coux O, Goldberg AL, Liang TJ (1999) Hepatitis B virus X protein is both a substrate and a potential inhibitor of the proteasome complex. J Virol 73:7231\u20137240","journal-title":"J Virol"},{"key":"3066_CR13","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.3748\/wjg.v11.i11.1705","volume":"11","author":"G-W Huang","year":"2005","unstructured":"Huang G-W, Yang L-Y, Lu W-Q (2005) Expression of hypoxia-inducible factor 1\u03b1 and vascular endothelial growth factor in hepatocellular carcinoma: impact on neovascularization and survival. World J Gastroenterol WJG 11:1705","journal-title":"World J Gastroenterol WJG"},{"key":"3066_CR14","doi-asserted-by":"publisher","first-page":"5598","DOI":"10.1128\/JCM.41.12.5598-5603.2003","volume":"41","author":"G-Y Hwang","year":"2003","unstructured":"Hwang G-Y et al (2003) Detection of the hepatitis B virus X protein (HBx) antigen and anti-HBx antibodies in cases of human hepatocellular carcinoma. J Clin Microbiol 41:5598\u20135603","journal-title":"J Clin Microbiol"},{"key":"3066_CR15","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/nm1440","volume":"12","author":"C-R Jung","year":"2006","unstructured":"Jung C-R, Hwang K-S, Yoo J, Cho W-K, Kim J-M, Kim WH, Im D-S (2006) E2-EPF UCP targets pVHL for degradation and associates with tumor growth and metastasis. Nat Med 12:809\u2013816","journal-title":"Nat Med"},{"key":"3066_CR16","doi-asserted-by":"publisher","first-page":"4493","DOI":"10.1172\/JCI42674","volume":"120","author":"C-R Jung","year":"2010","unstructured":"Jung C-R, Lim JH, Choi Y, Kim D-G, Kang KJ, Noh S-M, Im D-S (2010) Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice. J Clin Investig 120:4493","journal-title":"J Clin Investig"},{"key":"3066_CR17","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/hep.21137","volume":"43","author":"CR Jung","year":"2006","unstructured":"Jung CR et al (2006) Adenovirus-mediated transfer of siRNA against PTTG1 inhibits liver cancer cell growth in vitro and in vivo. Hepatology 43:1042\u20131052","journal-title":"Hepatology"},{"key":"3066_CR18","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1002\/j.1460-2075.1985.tb03774.x","volume":"4","author":"A Kay","year":"1985","unstructured":"Kay A, Mandart E, Trepo C, Galibert F (1985) The HBV HBX gene expressed in E. coli is recognised by sera from hepatitis patients. EMBO J 4:1287","journal-title":"EMBO J"},{"key":"3066_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/351317a0","volume":"351","author":"C-M Kim","year":"1991","unstructured":"Kim C-M, Koike K, Saito I, Miyamura T, Jay G (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351:317","journal-title":"Nature"},{"key":"3066_CR20","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.1840190403","volume":"19","author":"K Koike","year":"1994","unstructured":"Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T, Kurokawa K (1994) High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19:810\u2013819","journal-title":"Hepatology"},{"key":"3066_CR21","first-page":"21","volume":"2","author":"J Lee","year":"2012","unstructured":"Lee J, Zhou P (2012) Pathogenic role of the CRL4 ubiquitin ligase in human disease. Front Oncol 2:21","journal-title":"Front Oncol"},{"key":"3066_CR22","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/jcb.21914","volume":"105","author":"JH Lim","year":"2008","unstructured":"Lim JH, Jung CR, Lee CH, Im DS (2008) Egr-1 and serum response factor are involved in growth factors- and serum-mediated induction of E2-EPF UCP expression that regulates the VHL\u2013HIF pathway. J Cell Biochem 105:1117\u20131127","journal-title":"J Cell Biochem"},{"key":"3066_CR23","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1038\/mt.2011.302","volume":"20","author":"JH Lim","year":"2012","unstructured":"Lim JH, Shin HJ, Park K-S, Lee CH, Jung C-R, Im D-S (2012) Adenovirus-mediated E2-EPF UCP gene transfer prevents autoamputation in a mouse model of hindlimb ischemia. Mol Ther 20:778\u2013787","journal-title":"Mol Ther"},{"key":"3066_CR24","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1074\/jbc.271.5.2817","volume":"271","author":"Z Liu","year":"1996","unstructured":"Liu Z, Haas AL, Diaz LA, Conrad CA, Giudice GJ (1996) Characterization of a novel keratinocyte ubiquitin carrier protein. J Biol Chem 271:2817\u20132822","journal-title":"J Biol Chem"},{"key":"3066_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1155\/2001\/571254","volume":"17","author":"CR Madden","year":"2001","unstructured":"Madden CR, Slagle BL (2001) Stimulation of cellular proliferation by hepatitis B virus X protein. Dis Markers 17:153\u2013157","journal-title":"Dis Markers"},{"key":"3066_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/20459","volume":"399","author":"PH Maxwell","year":"1999","unstructured":"Maxwell PH et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271\u2013275","journal-title":"Nature"},{"key":"3066_CR27","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.3390\/v6114683","volume":"6","author":"MM Minor","year":"2014","unstructured":"Minor MM, Slagle BL (2014) Hepatitis B virus HBx protein interactions with the ubiquitin proteasome system. Viruses 6:4683\u20134702","journal-title":"Viruses"},{"key":"3066_CR28","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1096\/fj.03-0153fje","volume":"18","author":"E-J Moon","year":"2004","unstructured":"Moon E-J et al (2004) Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1\u03b1. FASEB J 18:382\u2013384","journal-title":"FASEB J"},{"key":"3066_CR29","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1002\/hep.25497","volume":"55","author":"B Nath","year":"2012","unstructured":"Nath B, Szabo G (2012) Hypoxia and hypoxia inducible factors: diverse roles in liver diseases. Hepatology 55:622\u2013633","journal-title":"Hepatology"},{"key":"3066_CR30","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/35017054","volume":"2","author":"M Ohh","year":"2000","unstructured":"Ohh M et al (2000) Ubiquitination of hypoxia-inducible factor requires direct binding to the \u03b2-domain of the von Hippel\u2013Lindau protein. Nat Cell Biol 2:423\u2013427","journal-title":"Nat Cell Biol"},{"key":"3066_CR31","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1111\/j.1349-7006.2007.00579.x","volume":"98","author":"N Oishi","year":"2007","unstructured":"Oishi N, Shilagardi K, Nakamoto Y, Honda M, Kaneko S, Murakami S (2007) Hepatitis B virus X protein overcomes oncogenic RAS-induced senescence in human immortalized cells. Cancer Sci 98:1540\u20131548","journal-title":"Cancer Sci"},{"key":"3066_CR32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1053\/j.gastro.2006.12.030","volume":"132","author":"R Pang","year":"2007","unstructured":"Pang R, Lee TK, Poon RT, Fan ST, Wong KB, Kwong YL, Tse E (2007) Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Gastroenterology 132:1088\u20131103","journal-title":"Gastroenterology"},{"key":"3066_CR33","first-page":"313","volume":"21","author":"P Paterlini","year":"1995","unstructured":"Paterlini P, Poussin K, Kew M, Franco D, Brechot C (1995) Selective accumulation of the X transcript of hepatitis B virus in patients negative for hepatitis B surface antigen with hepatocellular carcinoma. Hepatology 21:313\u2013321","journal-title":"Hepatology"},{"key":"3066_CR34","first-page":"467","volume":"26","author":"Z Peng","year":"2005","unstructured":"Peng Z et al (2005) Integration of the hepatitis B virus X fragment in hepatocellular carcinoma and its effects on the expression of multiple molecules: a key to the cell cycle and apoptosis. Int J Oncol 26:467\u2013473","journal-title":"Int J Oncol"},{"key":"3066_CR35","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/nrm1547","volume":"6","author":"MD Petroski","year":"2005","unstructured":"Petroski MD, Deshaies RJ (2005) Function and regulation of Cullin\u2013RING ubiquitin ligases. Nat Rev Mol Cell Biol 6:9\u201320","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3066_CR36","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0021-9258(18)89632-6","volume":"260","author":"CM Pickart","year":"1985","unstructured":"Pickart CM, Rose IA (1985) Functional heterogeneity of ubiquitin carrier proteins. J Biol Chem 260:1573\u20131581","journal-title":"J Biol Chem"},{"key":"3066_CR37","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/ncb0509-527","volume":"11","author":"F Randow","year":"2009","unstructured":"Randow F, Lehner PJ (2009) Viral avoidance and exploitation of the ubiquitin system. Nat Cell Biol 11:527\u2013534","journal-title":"Nat Cell Biol"},{"key":"3066_CR38","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S1471-4914(01)02090-1","volume":"7","author":"GL Semenza","year":"2001","unstructured":"Semenza GL (2001) Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7:345\u2013350","journal-title":"Trends Mol Med"},{"key":"3066_CR39","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/nrc1187","volume":"3","author":"GL Semenza","year":"2003","unstructured":"Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721\u2013732","journal-title":"Nat Rev Cancer"},{"key":"3066_CR40","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1002\/hep.27360","volume":"61","author":"BL Slagle","year":"2015","unstructured":"Slagle BL, Andrisani OM, Bouchard MJ, Lee CG, Ou JHJ, Siddiqui A (2015) Technical standards for hepatitis B virus X protein (HBx) research. Hepatology 61:1416\u20131424","journal-title":"Hepatology"},{"key":"3066_CR41","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1002\/hep.510270428","volume":"27","author":"Q Su","year":"1998","unstructured":"Su Q, Schr\u00f6der CH, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P (1998) Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 27:1109\u20131120","journal-title":"Hepatology"},{"key":"3066_CR42","doi-asserted-by":"publisher","first-page":"11263","DOI":"10.1158\/0008-5472.CAN-06-1699","volume":"66","author":"H Tanaka","year":"2006","unstructured":"Tanaka H et al (2006) Hypoxia-independent overexpression of hypoxia-inducible factor 1\u03b1 as an early change in mouse hepatocarcinogenesis. Cancer Res 66:11263\u201311270","journal-title":"Cancer Res"},{"key":"3066_CR43","doi-asserted-by":"publisher","first-page":"5388","DOI":"10.1128\/MCB.23.15.5388-5400.2003","volume":"23","author":"X Varelas","year":"2003","unstructured":"Varelas X, Ptak C, Ellison MJ (2003) Cdc34 self-association is facilitated by ubiquitin thiolester formation and is required for its catalytic activity. Mol Cell Biol 23:5388\u20135400","journal-title":"Mol Cell Biol"},{"key":"3066_CR44","doi-asserted-by":"publisher","first-page":"6621","DOI":"10.1038\/sj.onc.1207861","volume":"23","author":"KW Wagner","year":"2004","unstructured":"Wagner KW et al (2004) Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin. Oncogene 23:6621\u20136629","journal-title":"Oncogene"},{"key":"3066_CR45","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1073\/pnas.98.3.1176","volume":"98","author":"JB Welsh","year":"2001","unstructured":"Welsh JB et al (2001) Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer. Proc Natl Acad Sci 98:1176\u20131181","journal-title":"Proc Natl Acad Sci"},{"key":"3066_CR46","doi-asserted-by":"publisher","first-page":"18213","DOI":"10.1073\/pnas.0907887106","volume":"106","author":"A Williamson","year":"2009","unstructured":"Williamson A, Wickliffe KE, Mellone BG, Song L, Karpen GH, Rape M (2009) Identification of a physiological E2 module for the human anaphase-promoting complex. Proc Natl Acad Sci 106:18213\u201318218","journal-title":"Proc Natl Acad Sci"},{"key":"3066_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11684-013-0301-3","volume":"8","author":"CC-L Wong","year":"2014","unstructured":"Wong CC-L, Kai AK-L, Ng IO-L (2014) The impact of hypoxia in hepatocellular carcinoma metastasis. Front Med 8:33\u201341","journal-title":"Front Med"},{"key":"3066_CR48","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1158\/1078-0432.CCR-10-3096","volume":"17","author":"ZL Xiang","year":"2011","unstructured":"Xiang ZL, Zeng ZC, Fan J, Tang ZY, Zeng HY, Gao DM (2011) Gene expression profiling of fixed tissues identified hypoxia-inducible factor-1\u03b1, VEGF, and matrix metalloproteinase-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma. Clin Cancer Res 17(16):5463\u20135472","journal-title":"Clin Cancer Res"},{"key":"3066_CR49","doi-asserted-by":"publisher","first-page":"39076","DOI":"10.1074\/jbc.M305101200","volume":"278","author":"Y-G Yoo","year":"2003","unstructured":"Yoo Y-G et al (2003) Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1\u03b1 through activation of mitogen-activated protein kinase pathway. J Biol Chem 278:39076\u201339084","journal-title":"J Biol Chem"},{"key":"3066_CR50","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0168-8278(99)80172-X","volume":"31","author":"D-Y Yu","year":"1999","unstructured":"Yu D-Y et al (1999) Incidence of hepatocellular carcinoma in transgenic mice expressing the hepatitis B virus X-protein. J Hepatol 31:123\u2013132","journal-title":"J Hepatol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03066-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-019-03066-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-019-03066-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T06:25:57Z","timestamp":1663136757000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-019-03066-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,22]]},"references-count":50,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["3066"],"URL":"https:\/\/doi.org\/10.1007\/s00018-019-03066-9","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,22]]},"assertion":[{"value":"8 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}